Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology

DQ Huang, AG Singal, F Kanwal… - Nature Reviews …, 2023 - nature.com
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

[PDF][PDF] Trial design and endpoints in hepatocellular carcinoma: AASLD consensus conference

JM Llovet, A Villanueva, JA Marrero, M Schwartz… - …, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality
worldwide.(1, 2) This neoplasm has some unique characteristics. It occurs in most cases …

Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions

LY Mak, K Liu, S Chirapongsathorn, KC Yew… - Nature Reviews …, 2024 - nature.com
Globally, nearly half of deaths from cirrhosis and chronic liver diseases (CLD) and three-
quarters of deaths from hepatocellular carcinoma (HCC) occur in the Asia-Pacific region …

Hepatitis B virus-associated hepatocellular carcinoma

GEM Rizzo, G Cabibbo, A Craxì - Viruses, 2022 - mdpi.com
Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …

Hepatocellular carcinoma in chronic viral hepatitis: where do we stand?

FP Russo, A Zanetto, E Pinto, S Battistella… - International journal of …, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death.
Although the burden of alcohol-and NASH-related HCC is growing, chronic viral hepatitis …

Risk stratification and early detection biomarkers for precision HCC screening

YT Lee, N Fujiwara, JD Yang, Y Hoshida - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

[HTML][HTML] Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis

Z Liu, Y Zhang, M Xu, X Li, Z Zhang - Medicine, 2021 - journals.lww.com
Hepatitis B virus (HBV) genotypes and subgenotypes have distinct geographical
distributions and influence a number of clinical disease features and responses to treatment …

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis

C Campbell, T Wang, AL McNaughton… - Journal of viral …, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the leading contributors to cancer mortality
worldwide and is a leading cause of death in individuals with chronic hepatitis B virus (HBV) …

[HTML][HTML] Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection

CL Lin, JH Kao - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC)
in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors …

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

DQ Huang, A Tran, ML Yeh, S Yasuda, PC Tsai… - Hepatology, 2023 - journals.lww.com
Antiviral therapy substantially reduces HCC risk in patients... : Hepatology Antiviral therapy
substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate …